Advaxis News Releases

Date Title and Summary Additional Formats
February 13, 2018 Advaxis Submits Conditional Marketing Authorization Application for Axalimogene Filolisbac for the Second-Line Treatment of Metastatic Cervical Cancer in European Union
February 12, 2018 Advaxis Announces Publication of Phase 2 Results Evaluating Axalimogene Filolisbac for the Treatment of Recurrent Metastatic Cervical Cancer in the International Journal of Gynecological Cancer
February 8, 2018 Immunotherapy: A New Strategy for the Treatment of Cervical Cancer: Interview with Dr. Christian Marth and Dr. Sharad Ghamande
January 29, 2018 Data Highlighting Advaxis’ Antigen Delivery Platform Accepted for Multiple Presentations at 2018 Keystone Symposia Conference on Cancer Immunotherapies
January 25, 2018 Advaxis’ Immunotherapy in Combination with Chemoradiation Highlighted as Potential Treatment for Anal Cancer in International Journal of Radiation Oncology
January 23, 2018 Tolerability of ADXS11-001 Lm-LLO Listeria Based Immunotherapy With Mitomycin, Fluorouracil and Radiation for Anal Cancer
Displaying 131 - 136 of 136